A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
Abroad (travel likely)RecruitingPHASE3
Conditions
MF
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
West China Hospital Sichuan University, Chengdu, Sichuan, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), Tianjin, Tianjin Municipality, China
Study leads
Xiao Zhijian, Doctor
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)
Niu Ting, Doctor
Principal Investigator
West China Hospital
Miao Jia, Doctor
Principal Investigator
West China Hospital